Cook Medical's Zenith TX2 Thoracic TAA Endovascular Graft is designed for thoracic endovascular aortic repair (TEVAR).
May 27, 2008 - Cook Medical (Cook) has received approval from the FDA for its Zenith TX2 Thoracic TAA Endovascular Graft, marking the expansion of Cook Medical’s portfolio of devices to treat aortic diseases.
May 22, 2008 - MIV Therapeutics Inc. has enrolled the first patients in the registration trial of its VESTAsync polymer ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Medtronic introduced Profile 3D Annuloplasty Ring with a design based on the geometry of the saddle-shaped human mitral ...
May 22, 2008 - Nassir Marrouche, M.D., and his research team from the University of Utah School of Medicine received the ...
May 14, 2008 - Cook Medical launched at Health Rhythm Society 2008 the EVOLUTION-Shortie Mechanical Dilator Sheath Set ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
May 21, 2008 — According to a new study released at Heart Rhythm 2008, the Heart Rhythm Society’s 29th Annual Scientific ...
May 21, 2008 - Antiarrhythmic drug treatment during the six weeks following atrial fibrillation (AF) ablation is well ...
The latest addition to its HD ultrasound family of products, the Philips HD7, has launched in the U.S. and is designed ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 21, 2008 - Paramedics equipped with pre-hospital ECG devices that wirelessly transmit critical information to ...
May 21, 2008 - At the Heart Rhythm 2008 President's Reception on Friday, May 16, outgoing President Bruce Lindsay, M.D ...
May 21, 2008 - On the Heart Rhythm 2008 exhibit hall floor, Siemens Healthcare said it will extend its strategic ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 21, 2008 - LUMEDX Corp., a provider of cardiovascular imaging and information systems (CVIS), introduced software ...
May 21, 2008 - Dronedarone significantly reduces the incidence of cardiovascular hospitalization or death in patients with atrial fibrillation (AF), according to results of the ATHENA Trial presented at Heart Rhythm 2008.
May 13, 2008 - Medtronic received FDA premarket approval (PMA) for the first wave of cardiac rhythm disease management therapies under the new Vision 3D portfolio, which will comprise a full line of implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy-defibrillators (CRT-Ds), pacemakers and cardiac resynchronization therapy-pacemakers (CRT-Ps) to address the needs of p
May 26, 2008
